| answer text |
<p>We have considered this order.</p><p>There is no difference in the anti-malarial
drug Mefloquine (under the brand name Lariam) currently provided to the United Kingdom
and United States armed forces.</p><p>Mefloquine is effective in the prevention and
treatment of malaria. Approved by the Medicines and Health products Regulatory Agency,
the current product information states that neuropsychiatric adverse reactions may
occur during treatment and includes warnings and precautions to minimise these risks.
Some of these reactions may persist, but it has not been established whether these
are permanent.</p><p>Mefloquine continues to be recommended as a safe and effective
form of malaria prevention by the Advisory Committee on Malaria Prevention, the World
Health Organization and other respected organisations who take account of the body
of global evidence.</p>
|
 |
